Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Te Hsu

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|July 15, 2015
Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)₂D, leading to the 25(OH)D-induced growth inhibitionKun-Chun Chiang, Cho-Li Yen, Chun-Nan Yeh, et al.
International Journal of Molecular Sciences|April 26, 2016
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialKun-Chun Chiang, Ta-Sen Yeh, Shin-Cheh Chen, et al.
Cancer Letters|August 24, 2014
The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Abdominal Radiology (New York)|January 3, 2021
Alternative application of percutaneous cholecystostomy in patients with biliary obstructionHung-Yu Chung, Chih-Chieh Hsu, Yu-Liang Hung, et al.
Frontiers in Endocrinology|February 23, 2023
Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatmentYu-Chi Kuo, Shang-Yu Wang, Yu-Liang Hung, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 16, 2013
MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitroKun-Chun Chiang, Shin-Cheh Chen, Chun-Nan Yeh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 19, 2013
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomeraseKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Anticancer Research|June 30, 2016
1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and ApoptosisKun-Chun Chiang, Chun-Nan Yeh, Jong-Hwei S Pang, et al.
Drug Design, Development and Therapy|August 29, 2015
PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivoKun-Chun Chiang, Huang-Yang Chen, Shu-Yuan Hsu, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Steroid Biochemistry and Molecular Biology|July 15, 2015
Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)₂D, leading to the 25(OH)D-induced growth inhibitionKun-Chun Chiang, Cho-Li Yen, Chun-Nan Yeh, et al.
International Journal of Molecular Sciences|April 26, 2016
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialKun-Chun Chiang, Ta-Sen Yeh, Shin-Cheh Chen, et al.
Cancer Letters|August 24, 2014
The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Abdominal Radiology (New York)|January 3, 2021
Alternative application of percutaneous cholecystostomy in patients with biliary obstructionHung-Yu Chung, Chih-Chieh Hsu, Yu-Liang Hung, et al.
Frontiers in Endocrinology|February 23, 2023
Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatmentYu-Chi Kuo, Shang-Yu Wang, Yu-Liang Hung, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 16, 2013
MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitroKun-Chun Chiang, Shin-Cheh Chen, Chun-Nan Yeh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 19, 2013
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomeraseKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Anticancer Research|June 30, 2016
1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and ApoptosisKun-Chun Chiang, Chun-Nan Yeh, Jong-Hwei S Pang, et al.
Drug Design, Development and Therapy|August 29, 2015
PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivoKun-Chun Chiang, Huang-Yang Chen, Shu-Yuan Hsu, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
Pageof 17